OTCMKTS:ABCZY - ABCAM PLC/ADR Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $16.0530 -0.24 (-1.47 %) (As of 11/13/2018 04:00 PM ET)Previous Close$16.2950Today's Range$16.0530 - $16.053052-Week Range$12.7506 - $20.2875Volume265 shsAverage Volume778 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta1.84 ProfileDiscussionChartDividendHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery products and services. Abcam plc also engages in sales and distribution, and financing and investing activities, as well as sells its products online. It offers validated antibodies and other binders, and assays to the research and clinical communities to help advance the understanding of biology and causes of disease. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom. Receive ABCZY News and Ratings via Email Sign-up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Industrial inorganic chemicals, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ABCZY Previous SymbolNASDAQ:ABCZY CUSIPN/A WebN/A PhoneN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares204,960,000Market Cap$0.00 OptionableNot Optionable ABCAM PLC/ADR (OTCMKTS:ABCZY) Frequently Asked Questions What is ABCAM PLC/ADR's stock symbol? ABCAM PLC/ADR trades on the OTCMKTS under the ticker symbol "ABCZY." How often does ABCAM PLC/ADR pay dividends? What is the dividend yield for ABCAM PLC/ADR? ABCAM PLC/ADR declared a Semi-Annual dividend on Tuesday, September 11th. Stockholders of record on Friday, November 9th will be paid a dividend of $0.091 per share on Friday, December 14th. The ex-dividend date of this dividend is Thursday, November 8th. This is an increase from ABCAM PLC/ADR's previous Semi-Annual dividend of $0.04. View ABCAM PLC/ADR's Dividend History. Has ABCAM PLC/ADR been receiving favorable news coverage? Press coverage about ABCZY stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. ABCAM PLC/ADR earned a news sentiment score of 1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. Who are some of ABCAM PLC/ADR's key competitors? Some companies that are related to ABCAM PLC/ADR include 22nd Century Group (XXII), 3D Signatures (DXD), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abaxis (ABAX), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acerus Pharmaceuticals (ASP), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Activecare (ACAR) and Advanced Accelerator Application (AAAP). Who are ABCAM PLC/ADR's key executives? ABCAM PLC/ADR's management team includes the folowing people: Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 50)Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 53)Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 48)James Staveley, VP of Investor RelationsMs. Suzanne E. Smith LLB (Hons), MBA, Chief Legal Officer & Company Sec. How do I buy shares of ABCAM PLC/ADR? Shares of ABCZY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ABCAM PLC/ADR's stock price today? One share of ABCZY stock can currently be purchased for approximately $16.0530. MarketBeat Community Rating for ABCAM PLC/ADR (OTCMKTS ABCZY)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 67 (Vote Outperform)Underperform Votes: 80 (Vote Underperform)Total Votes: 147MarketBeat's community ratings are surveys of what our community members think about ABCAM PLC/ADR and other stocks. Vote "Outperform" if you believe ABCZY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABCZY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/13/2018 by MarketBeat.com StaffFeatured Article: Stock Selection - What is cash flow?